Calla Lily Clinical Care

📍 London, United Kingdom🗓 Founded 2021👥 29 employees💰 Last funded Mar 2024
Calla Lily Clinical Care is a British medical device startup developing Callavid®: a leak-free, convenient and dosage-confident delivery platform for vaginally-delivered drugs. We are initially focused on delivering progesterone for miscarriage prevention and IVF, where there is an unmet need for a patient-friendlier means of drug administration during an already stressful fertility journey. Progesterone prescriptions have significantly increased following the Nov 2021 update to internationally-renowned NICE’s guidance on miscarriages. Callavid® can also deliver menopausal treatments, targeted cancer treatments, and live biotherapeutics (LBPs) cutting antibiotic usage and reducing the spread of antimicrobial resistance (AMR). For pharmaceutical partners, Callavid® offers a differentiated drug delivery modality for pipeline drugs, and a means of extending the lifecycle of established assets including off-patent therapeutics. Our patented technology has received FDA clearance and was named one of TIME magazine’s Best Inventions of the Year.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2021
Founded
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Calla Lily Clinical Care?
Calla Lily Clinical Care has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Calla Lily Clinical Care last raise funding?
The most recent investment in Calla Lily Clinical Care recorded on gritt.io was in March 2024.
When was Calla Lily Clinical Care founded?
Calla Lily Clinical Care was founded in 2021.
What industry is Calla Lily Clinical Care in?
Calla Lily Clinical Care operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Calla Lily Clinical Care based?
Calla Lily Clinical Care is headquartered in London, United Kingdom.